High expression of GADD-45α and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6

International Journal of Oncology

Volumn 32, Issue 2, 2008, Pages 397-403

  Ohtani, K ^a   Usuda, J ^a   Ichinose, S ^a   Ishizumi, T ^a   Hirata, T ^a   Inoue, T ^a   Maehara, S ^a   Imai, K ^a   Kubota, M ^a   Tsunoda, Y ^a   Yamada, M ^a   Tsutsui, H ^a   Yamada, K ^a   Kuroiwa, Y ^a   Furukawa, K ^b   Okunaka, T ^c   Kato, H ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b Tokyo Medical University Ibaraki Medical Center   (Japan)

^c INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

NPe6; Photodynamic therapy; Recurrence

Indexed keywords

GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; INTERLEUKIN 2; MESSENGER RNA; NPE 6; TALAPORFIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RESISTANCE; CELL DEATH; CLONOGENESIS; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; LUNG CARCINOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; TUMOR RECURRENCE; TUMOR VASCULARIZATION; UPREGULATION;

EID: 38849184082     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.32.2.397     Document Type: Article

References (32)

1. Dougherty TJ, Gomer CJ, Barbara WH, et al: Photodynamic therapy. J Natl Cancer Inst 90: 889-905, 1998.
2. Henderson BW and Dougherty TJ: How does photodynamic therapy work? Photochem Photobiol 55: 145-157, 1992.
3. Oleinick NL, Morris RL and Belichenko I: The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci 1: 1-21, 2001.
4. Gomer CJ, Ferrario A, Luna M, et al: Photodynamic therapy: combined modality approaches targeting the tumor microenvironment. Lasers Surg Med 38: 516-521, 2006.
5. Dougherty TJ: An update on photodynamic therapy applications. J Clin Laser Med Surg 20: 3-7, 2002.
6. Usuda J, Kato H, Okunaka T, et al: Photodynamic therapy for lung cancers. J Thorac Oncol 1: 489-493, 2006.
7. Kato H, Usuda J, Okunaka T, et al: Basic and clinical research on photodynamic therapy at Tokyo Medical University Hospital. Lasers Surg Med 38: 371-375, 2006.
8. Kato H, Furukawa K, Sato M, et al: Phase II clinical study of photodynamic therapy using mono-L-asparty1 chlorine e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer 42: 103-111, 2003.
9. Furukawa K, Kato H, Konaka C, et al: Locally recurrent central-type early stage lung cancer <1.0 cm in diameter after complete remission by photodynamic therapy. Chest 128: 33269-3275, 2005.
10. Usuda J, Tsutsui H, Honda H, et al: Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) anal autofluorescence brinchoscopy. Lung Cancer (In press).
11. Sitink TM, Hampton JA, Henderson BW, et al: Reduction of tumor oxygenation during and after photodynamic therapy in vivo: effect of fluence rate. Br J Cancer 77: 1386-1394, 1998.
12. Ferrario A, von Tiehil KF, Rucker N, Schwartz MA, Gill PS and Gomer CJ: Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res 60: 4066-4069, 2000.
13. sl0 (Na) and expression of the vascular endothelial growth factor in vivo. Oncol Rep 18: 679-683, 2007.
14. Usuda J, Okunaka T, Furukawa K, et al: lncreased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis. Int J Cancer 93: 475-480, 2001.
15. Korbelik M: PDT-associated host response and its role in the therapy outcome. Lasers Surg Med 38: 500-508, 2006.
16. Gollnick SO, Owczarczak Band Maier P: Photodynamic therapy and anti-tumor immunity. Lasers Surg Med 38: 509-515, 2006.
17. Sugiura K and Stock CC: Studies in a tumor spectrum. III. The, effect of phosphoramides on the growth of a variety of mouse and rat. Cancer Res 15: 38-51, 1955.
18. Ohe Y, Podack ER, Olsen KJ, Ohira T, Miura K, Nishio K, et al: Combination effect of vaccination with IL-2 and IL-4 cDNA transfected cells on the induction of a therapeutic immune response against Lewis lung carcinoma cells. Int J Cancer 53: 432-437, 1993.
19. Ohe Y, Podack ER, Olsen KJ, Miura K, Saito H, Koshihara Y, et al: Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumor growth rate but cause weight loss and shorten survival in syngenic mice. Br J Cancer 67: 939-944, 1993.
20. Natsume T, Watanabe J, Koh Y, et al: Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivo. Cancer Sci 94: 826-833, 2003.
21. Koizumi F, Kitagawa M, Negishi T, et al: Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors. Cancer Res 66: 10048-10056, 2006.
22. Nakamura H, Saji H, Ogata A, et al: cDNA microarray analysis of gene expression in pathologic stage IA non-small cell lung cancer. Cancer 97: 2798-2805, 2003.
23. Chinose S, Usuda J, Hirata T, et al: Lysosomal cathepsin initiates apoptosis, which is regulated by photodamage to Bcl-2 at mitochondria in photodynamic therapy using a novel photosensitizer, ATX-sl0 (Na). Int J Oncol 29: 349-355, 2006.
24. Usuda J, Azizuddin K, Chiu SM, et al: Association between the photodynamic loss of Bcl-2 and the sensitivity to apoptosis caused by phthalocyanine photodynamic therapy. Photochem Photobiol 78: 1-8, 2003.
25. Ferrario A, Chantrain CF, von Tiehl Karl et al: The matrix metalloproteinase inhibitor primastat enhances photodynamic therapy responsiveness in a mouse tumor model. Cancer Res 64: 2328-2332, 2004.
26. Oyadomori S and Mori M: Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11: 381-389, 2004.
27. Wong S, Luna M, Ferrario A, et al: CHOP activation by photodynamic therapy increases treatment induced photosensitization. Lasers Surg Med 35: 336-341, 2004.
28. Hoffmeyer A, Poekorz R, Moriggl R, et al: Gadd45 is dispensable for normal mouse development and T-cell proliferation. Mol Cell Biol 21: 3137-3143, 2001.
29. Gupta M, Gupta SK, Hoffman B, et al: Gadd45a and Gadd45b protect hematopoietic cells from UV-induced apoptosis via distinct signaling pathways, including p38 activation and JNK inhibition. J Biol Chem 281: 17552-17558, 2006.
30. Solban N, Rizvi I and Hasan T: Targeted photodynamic therapy. Lasers Surg Med 38: 522-531, 2006.
31. Jiang F, Zhang ZG, Katakowski M, et al: Angiogenesis induced by photodynamic therapy in normal rat brain. Photochem Photobiol 79: 494-498, 2004.
32. Mor F, Quintana FJ and Cohen IR: Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 172: 4618-4623, 2004.